Cystic Fibrosis News

First Participant Dosed with SNSP113 in CF Trial, Synspira Announces - Cystic Fibrosis News Today



Cystic Fibrosis News Today
 
First Participant Dosed with SNSP113 in CF Trial, Synspira Announces 
Cystic Fibrosis News Today
Synspira has started a Phase 1a clinical trial to determine the safety and tolerability of its cystic fibrosis therapy candidate SNSP113 in healthy volunteers and eventually in patients with stable CF. The dosing of the first participant marked the ...

 


Vertex Plans $500M, 10-Year Charitable Effort Spanning Aid to CF Community and Science Education - Cystic Fibrosis News Today



Cystic Fibrosis News Today
 
Vertex Plans $500M, 10-Year Charitable Effort Spanning Aid to CF Community and Science Education 
Cystic Fibrosis News Today
Vertex Pharmaceuticals announced the start of a $500 million, 10-year charitable commitment to cystic fibrosis (CF) and other patients using its treatments, young adults studying science and mathematics, and communities across the U.S. The effort ...

 


New 3-D visualization tool could enable targeted drug delivery for ... - Phys.Org



Phys.Org
 
New 3-D visualization tool could enable targeted drug delivery for ... 
Phys.Org
University of California San Diego researchers have developed the first 3D spatial visualization tool for mapping "'omics" data onto whole organs. The tool helps ...

and more » 


Lubbock Taste Tour to raise money for Cystic Fibrosis Foundation - KCBD-TV



Lubbock Taste Tour to raise money for Cystic Fibrosis Foundation 
KCBD-TV
The Lubbock Taste Tour is returning to the South Plains for the 5th year to benefit the Cystic Fibrosis Foundation. This year's event will take place at the Stone Creek Special Events Center on Friday, October 20 from 7 p.m. to 11 p.m.. Savor cuisine ...

 


HOPE-1 Clinical Trial for SPX-101 Is Enrolling CF Patients in Canada and Europe - Cystic Fibrosis News Today



HOPE-1 Clinical Trial for SPX-101 Is Enrolling CF Patients in Canada and Europe 
Cystic Fibrosis News Today
The first patient has been enrolled and dosed in the HOPE-1 Phase 2 clinical trial evaluating Spyryx Biosciences' investigational drug SPX-101 as a treatment for cystic fibrosis (CF). The HOPE-1 study (NCT03229252) will take place in Alberta and ...

 


How to Fight 'FOMO' - Cystic Fibrosis News Today



Cystic Fibrosis News Today
 
How to Fight 'FOMO' 
Cystic Fibrosis News Today
Cystic fibrosis has forced me to miss out on more than I could ever keep track of. Earlier this year, I missed a spring break trip to North Carolina with 12 of my friends because I was stuck in the hospital. Less than a month later, another ...

 


Life with cystic fibrosis: A Louisville man's story of triumph - wave3 ... - WAVE 3



Stuff.co.nz
 
Life with cystic fibrosis: A Louisville man's story of triumph - wave3 ... 
WAVE 3
LOUISVILLE, KY (WAVE) - Imagine feeling like every breath you taking is through a small straw; that's what it's like to have Cystic Fibrosis. Thick mucus clogs the ...
Cystic fibrosis patient inspires pole dancing fundraiser event | Stuff ... Stuff.co.nz

all 2 news articles » 


Healthier Ways to Help Gain Weight - Cystic Fibrosis News Today



Cystic Fibrosis News Today
 
Healthier Ways to Help Gain Weight 
Cystic Fibrosis News Today
Gaining weight can be just as difficult as maintaining lung function for many with cystic fibrosis. Most have heard people without CF joke that they wish they had our problem with gaining weight. But for those who experience the struggle of ...

 


Cystic Fibrosis Lung Micro-organisms Study Turns Up Predatory ... - Cystic Fibrosis News Today



Cystic Fibrosis Lung Micro-organisms Study Turns Up Predatory ... 
Cystic Fibrosis News Today
Read about Spanish researchers discovering two predator bacteria among the micro-organisms in the lungs of cystic fibrosis patients.

and more » 


#NORDsummit - Orphan Drug Act Is Working to Advance Rare ... - Cystic Fibrosis News Today



#NORDsummit - Orphan Drug Act Is Working to Advance Rare ... 
Cystic Fibrosis News Today
As Congress begins debate this week to overhaul the U.S. tax code, lawmakers should leave the Orphan Drug Act (ODA) ? and the tax incentives it offers ...

and more »